MedPath

oninvasive vagal nerve stimulation for abdominal symptoms in people with spinal cord injury

Not Applicable
Conditions
Abdominal pain
spinal cord injury
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Musculoskeletal - Other muscular and skeletal disorders
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Neurological - Other neurological disorders
Injuries and Accidents - Other injuries and accidents
Registration Number
ACTRN12624000010594
Lead Sponsor
Royal North Shore Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Patients with spinal cord injury for at least 12 months
Currently experiencing abdominal symptoms, including abdominal pain/discomfort

Exclusion Criteria

Unable to complete questionnaires – whether due to impaired cognition or language barrier
Unable to deliver vagal nerve stimulation by him/herself OR does not have someone else who can deliver the VNS
Unable to attend required face-to-face visits
Any other implant device that may interfere with vagal nerve stimulation
Underlying significant cardiac abnormality, especially cardiac arrhythmia
(Relative contraindication) History of recurrent or severe autonomic dysreflexia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain scale - Ten point visual analogue scale<br>[ Assessed using at week 0, 4, 8 and 12. Ten point visual analogue was designed based from international spinal cord injury pain basic data set/ bowel function data set.];Abdominal pain map - Participant marks locations of the pain on diagram of abdomen/back[ Assessed using online questionnaire at week 0, 4, 8 and 12. This online interactive abdominal pain map was developed specifically for this study.]
Secondary Outcome Measures
NameTimeMethod
Colonic motility[ Assessed using abdominal x-ray after consuming oral contrast marker(Eg. Sitzmark) at week 0 and 12];Autonomic dysreflexia[ Patients will be asked if they had autonomic dysreflexia event at 0, 4, 8 and 12. No specific pre-validated questionnaire was used.];Quality of life using ten point visual analogue scale.[ Assessed using at week 0, 4, 8 and 12. Ten point visual analogue was designed based from international spinal cord injury pain basic data set/ bowel function data set.]
© Copyright 2025. All Rights Reserved by MedPath